Xiangyang No.1 People's Hospital
1 clinical trials · Sponsor
◉ Watch Xiangyang No.1 People's Hospital
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma (NCT05909098) | Xiangyang No.1 People's Hospital | 2023-07-01 |
Track Xiangyang No.1 People's Hospital automatically
Every clearance here is in the API, with alerts when new ones post.